74%
de inversores minoristas pierde dinero cuando opera con CFDs en este proveedor.
Las inversiones conllevan riesgos y no son adecuadas para todos los inversores. Los CFDs son instrumentos complejos y tienen un alto riesgo de perder dinero rápidamente debido al apalancamiento.
74%
de inversores minoristas pierde dinero cuando opera con CFDs en este proveedor.
Debes considerar si comprendes cómo funcionan los CFDs y si puedes permitirte asumir el alto riesgo de perder tu dinero.
74%
de inversores minoristas pierde dinero cuando opera con CFDs en este proveedor.
Las inversiones conllevan riesgos y no son adecuadas para todos los inversores. Los CFDs son instrumentos complejos y tienen un alto riesgo de perder dinero rápidamente debido al apalancamiento.
74%
de inversores minoristas pierde dinero cuando opera con CFDs en este proveedor.
Debes considerar si comprendes cómo funcionan los CFDs y si puedes permitirte asumir el alto riesgo de perder tu dinero.
Afya Ltd (Class A)
Cerrado
SectorConsumo defensivo
13.5 0.37
Resumen
Variación precio
24h
Mínimo
13.28
Máximo
13.52
Ingresos | -13M 181M |
|---|---|
Ventas | 9.1M 929M |
P/B Media del Sector | 9.046 32.611 |
Rentabilidad por dividendo | 1.67 |
Margen de beneficios | 19.455 |
EBITDA | -28M 397M |
Recomendaciones | Neutral |
|---|---|
Estimación a 12 Meses | +29.41% upside |
Rentabilidad por dividendo Media del Sector | 1.67% 3.35% |
|---|---|
Próximas Ganancias | 12 mar 2026 |
Capitalización Mercado | -50M 1.3B |
|---|---|
Apertura anterior | 13.13 |
Cierre anterior | 13.5 |
Noticias sobre sentimiento de mercado
By Acuity
100%
0%
126 / 132 Clasificación en Consumer defensive
Puntuación técnica
By Trading Central
Confianza
Bullish Evidence
Afya Ltd (Class A) Gráfico
Resultados pasados no son un indicador fiable de resultados futuros.
Noticias Relacionadas
Comparación entre iguales
Cambio de precio
Afya Ltd (Class A) previsión
Precio Objetivo
By TipRanks
29.41% repunte
Estimación a 12 Meses
Media 17.6 USD 29.41%
Máximo 22 USD
Mínimo 16 USD
De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Afya Ltd (Class A) Dist en los últimos 3 meses.
Finanzas
Gastos de venta y administración
Gastos operativos
Beneficio antes de impuestos
Ventas
Coste de ventas
Beneficio bruto de ventas
Gasto por intereses de deuda
EBITDA
Beneficio operativo
$
Acerca de Afya Ltd (Class A)
Afya Limited operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. Further, it offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.
Live chat